Topic summary
89%19 analyzed articles/videos18,797 analyzed words
BS Summary: These Medical Research results contain 52 faulty reasoning types, including Negativity Bias, Optimism Bias, and Biased Writer Voice, with Framing Effect as the most egregious example at 9.4% saturation with 7,710 hits. Analysis detected 61,488 faulty-reasoning hits from 82,100 analyzed words across 19 articles, generating a BS Score of 1.4% and a BS Rank of 18% (20,239 of 24,545 topics). This Medical Research is better (less manipulative) than 82.50% of the peer group.

Ranking context

Position among analyzed topics

18% percentile
025507510017.5% percentile
1.4% BS Score19 analyzed articles82.1K analyzed words

Reasoning profile

Selected profile versus the sitewide rate

TopicSitewideShared scale 0–50%
0.0%10%20%30%40%50%Framing EffectSitewide 26.9%Topic 9.4%9.4%Negativity BiasSitewide 19.2%Topic 6.6%6.6%Appeal to EmotionSitewide 15.9%Topic 3.9%3.9%In-Group BiasSitewide 6.9%Topic 0.6%0.6%Availability HeuristicSitewide 9.1%Topic 2.8%2.8%Appeal to AuthoritySitewide 11.1%Topic 5.1%5.1%Halo EffectSitewide 6.7%Topic 1.3%1.3%Confirmation BiasSitewide 7.5%Topic 3.0%3.0%Hasty GeneralizationSitewide 8.1%Topic 4.6%4.6%Anchoring BiasSitewide 4.0%Topic 1.0%1.0%

Sitewide departure map

Above the diagonal means this profile uses the pattern more often

0.0%0.0%10%10%20%20%30%30%40%40%50%50%Framing Effect: Topic 9.4%, sitewide 26.9%Negativity Bias: Topic 6.6%, sitewide 19.2%Appeal to Emotion: Topic 3.9%, sitewide 15.9%Appeal to Authority: Topic 5.1%, sitewide 11.1%Availability Heuristic: Topic 2.8%, sitewide 9.1%Hasty Generalization: Topic 4.6%, sitewide 8.1%Confirmation Bias: Topic 3.0%, sitewide 7.5%In-Group Bias: Topic 0.6%, sitewide 6.9%Halo Effect: Topic 1.3%, sitewide 6.7%Optimism Bias: Topic 6.5%, sitewide 6.0%Biased Writer Voice: Topic 5.8%, sitewide 5.3%Anecdotal: Topic 2.9%, sitewide 5.2%Overconfidence Bias: Topic 1.8%, sitewide 4.6%Anchoring Bias: Topic 1.0%, sitewide 4.0%Self-Serving Bias: Topic 1.1%, sitewide 3.7%Post Hoc (False Cause): Topic 2.2%, sitewide 3.3%Out-Group Homogeneity Bias: Topic 0.2%, sitewide 3.1%Fundamental Attribution Error: Topic 0.7%, sitewide 2.7%Recency Bias: Topic 1.0%, sitewide 2.7%Loss Aversion: Topic 0.7%, sitewide 2.5%Bandwagon: Topic 0.4%, sitewide 2.2%Status Quo Bias: Topic 0.8%, sitewide 2.2%Ad Hominem: Topic 1.3%, sitewide 2.2%Politically Left Leaning Bias: Topic 0.1%, sitewide 2.0%Framing EffectSitewide rateTopic rate

Analyzed articles and videos

Penn receives $10 million to study new treatment for ‘relentless,’ rare genetic disease with no cure16%
The Philadelphia Inquirer39%By Kayla Yup16%8/4/2026, 3:01:00 AM
Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare47%
KFF Health News37%By Arthur Allen65%7/29/2026, 2:00:00 AM
Under New Proposal, OHSU Primate Center Would Change Gears. But Some Animal Tests Would Go On.36%
Willamette Week40%By Andrew Schwartz44%7/22/2026, 3:23:27 PM
Women suffer more severe neurologic symptoms from long COVID than men, researchers find45%
Chicago Sun-Times48%By Elvia Malagón46%7/21/2026, 3:45:48 PM
Can Ozempic prevent or treat cancer? It's way too soon to say, an expert cautions18%
Live Science19%By Ziyad Al-Aly22%7/19/2026, 12:00:00 PM
Human vaccine trials for latest Ebola outbreak begin in the UK94%
Semafor90%By Jeronimo Gonzalez99% Jenny Vaughan93%7/15/2026, 6:58:39 AM
STAT+: Dementia study replicates promising outcomes following risk-reduction strategies58%
STAT62%By Andrew Joseph74%7/13/2026, 9:49:15 AM
Researchers launch study on Ebola treatments as Congo outbreak worsens48%
ABC News45%By LAURAN NEERGAARD AP medical writer0%7/2/2026, 9:25:37 AM
Semaglutide may lower risk of serious complications in high-risk diabetes26%
Medical News Today33%By Peter Morales-Brown52%7/2/2026, 8:46:30 AM
A patient got the weight loss medication retatrutide before FDA approval. How does that work?16%
PolitiFact22%By Madison Czopek27%6/30/2026, 5:00:00 PM